{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:56:11Z","timestamp":1791420971170,"version":"4.3.3"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.yjmcc.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:31:46Z","timestamp":1607473906000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review"],"prefix":"10.1016","volume":"152","author":[{"given":"Petra","family":"Mamic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanat","family":"Chaikijurajai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.yjmcc.2020.12.001_bb0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the Management of Heart Failure","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.06.1179","article-title":"Intestinal blood flow in patients with chronic heart failure: A link with bacterial growth, gastrointestinal symptoms, and Cachexia","volume":"64","author":"Sandek","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2007.11.103","article-title":"Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure","volume":"125","author":"Arutyunov","year":"2008","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0025","first-page":"220","article-title":"Pathogenic gut Flora in patients with chronic heart failure","volume":"4","author":"Pasini","year":"2016","journal-title":"JACC: Heart Failure."},{"issue":"9167","key":"10.1016\/j.yjmcc.2020.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebauer","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","article-title":"Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure","volume":"5","author":"Peschel","year":"2003","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/eht271","article-title":"The heart and the gut","volume":"35","author":"Rogler","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI116933","article-title":"Na+\/H+ exchangers, NHE-1 and NHE-3, of rat intestine","volume":"93","author":"Bookstein","year":"1994","journal-title":"Expression and localization. J Clin Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0050","first-page":"C629","article-title":"Age- and tissue-specific induction of NHE3 by glucocorticoids in the rat small intestine","volume":"278","author":"Kiela","year":"2000","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0055","doi-asserted-by":"crossref","first-page":"G909","DOI":"10.1152\/ajpgi.90312.2008","article-title":"Aldosterone regulation of intestinal Na absorption involves SGK-mediated changes in NHE3 and Na+ pump activity","volume":"295","author":"Musch","year":"2008","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0060","doi-asserted-by":"crossref","first-page":"G51","DOI":"10.1152\/ajpgi.00529.2001","article-title":"Metabolic acidosis in rats increases intestinal NHE2 and NHE3 expression and function","volume":"283","author":"Lucioni","year":"2002","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.049","article-title":"Meta\u2019omic Analytic Techniques for Studying the Intestinal Microbiome","volume":"146","author":"Morgan","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cgh.2018.09.017","article-title":"Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians","volume":"17","author":"Allaband","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.12.001_bb0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/1469-0691.12023","article-title":"Microbial culturomics: paradigm shift in the human gut microbiome study","volume":"18","author":"Lagier","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174099","article-title":"Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure","volume":"12","author":"Kamo","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ehf2.12155","article-title":"Heart failure is associated with depletion of core intestinal microbiota","volume":"4","author":"Luedde","year":"2017","journal-title":"ESC Heart Failure."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1253\/circj.CJ-17-1285","article-title":"Non-Ischemic Heart Failure With Reduced Ejection Fraction Is Associated With Altered Intestinal Microbiota","volume":"25","author":"Katsimichas","year":"2018","journal-title":"Circ J."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","article-title":"Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts","volume":"71","author":"Kummen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","article-title":"Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients","volume":"8","author":"Cui","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ehf2.12596","article-title":"Low fibre intake is associated with gut microbiota alterations in chronic heart failure","volume":"7","author":"Mayerhofer","year":"2020","journal-title":"ESC Heart Failure."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.healun.2020.02.004","article-title":"Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant","volume":"39","author":"Yuzefpolskaya","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cardfail.2016.06.005","article-title":"Hospitalized patients with heart failure and common bacterial infections: A Nationwide analysis of concomitant Clostridium difficile infection rates and in-hospital mortality","volume":"22","author":"Mamic","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(19)31358-0","article-title":"GUT MICROBIOME DIFFERS BETWEEN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND AGE-MATCHED CONTROLS","volume":"73","author":"Hummel","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0125","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","article-title":"The gut microbiome in coronary artery disease and heart failure: current knowledge and future directions","volume":"52","author":"Tr\u00f8seid","year":"2020","journal-title":"EBioMedicine."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"7418","key":"10.1016\/j.yjmcc.2020.12.001_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fmicb.2020.01065","article-title":"The relationship between gut microbiota and inflammatory diseases: the role of macrophages","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0150","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"PNAS."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.016","article-title":"A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors","volume":"180","author":"Nemet","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0160","doi-asserted-by":"crossref","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","volume":"133","author":"Davie","year":"2003","journal-title":"J. Nutr."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0165","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"PNAS."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/gmic.27492","article-title":"A novel SCFA receptor, the microbiota, and blood pressure regulation","volume":"5","author":"Pluznick","year":"2014","journal-title":"Gut Microbes"},{"issue":"6351","key":"10.1016\/j.yjmcc.2020.12.001_bb0175","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-\u03b3-signaling inhibits dysbiotic Enterobacteriaceae expansion","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0180","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation."},{"issue":"17","key":"10.1016\/j.yjmcc.2020.12.001_bb0185","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","article-title":"Deficiency of prebiotic Fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease","volume":"141","author":"Kaye","year":"2020","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0190","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-Fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Chen hung-Chih, Chen Chen-Yun, yen Christopher Y.T., Lin Chen-Ju, Prajnamitra ray P., et al. loss of gut microbiota alters immune system composition and cripples Postinfarction cardiac repair","volume":"139","author":"Tang Tony","year":"2019","journal-title":"Circulation."},{"issue":"17","key":"10.1016\/j.yjmcc.2020.12.001_bb0200","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.116.025338","article-title":"Gut microbe-generated trimethylamine N-oxide from dietary choline is Prothrombotic in subjects","volume":"135","author":"Zhu","year":"2017","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","article-title":"Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women","volume":"40","author":"Wang","year":"2019","journal-title":"Eur. Heart J."},{"issue":"7341","key":"10.1016\/j.yjmcc.2020.12.001_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l -carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0220","doi-asserted-by":"crossref","first-page":"1700299","DOI":"10.1002\/mnfr.201700299","article-title":"The effect of different l-carnitine administration routes on the development of atherosclerosis in ApoE knockout mice","volume":"62","author":"Zhao","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet Hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","article-title":"Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure","volume":"9","author":"Organ","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2017.00139","article-title":"Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in Western diet-induced obese mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0245","doi-asserted-by":"crossref","unstructured":"Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies. Journal of the American Heart Association. 6(7):e004947.","DOI":"10.1161\/JAHA.116.004947"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"39","key":"10.1016\/j.yjmcc.2020.12.001_bb0255","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.yjmcc.2020.12.001_bb0260","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J. Card. Fail."},{"issue":"18","key":"10.1016\/j.yjmcc.2020.12.001_bb0270","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.yjmcc.2020.12.001_bb0275","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.jacc.2017.10.064","article-title":"Trimethylamine-N-oxide and heart failure with reduced versus preserved ejection fraction","volume":"70","author":"Schuett","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0280","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.12328","article-title":"Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure","volume":"277","author":"Tr\u00f8seid","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0285","doi-asserted-by":"crossref","unstructured":"Suzuki T, Heaney LM, Bhandari SS, Jones DJL, Ng LL. Trimethylamine N-oxide and prognosis in acute heart failure. Heart. 2016 01;102(11):841\u20138.","DOI":"10.1136\/heartjnl-2015-308826"},{"issue":"7682","key":"10.1016\/j.yjmcc.2020.12.001_bb0290","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080604","article-title":"Commensal Bacteria-dependent indole production enhances epithelial barrier function in the Colon","volume":"8","author":"Shimada","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0300","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2010","journal-title":"PNAS."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0310","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","article-title":"Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of Interleukin-10 receptor","volume":"188","author":"Alexeev","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0320","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2014.10.032","article-title":"Bacterial metabolite indole modulates incretin secretion from intestinal Enteroendocrine L cells","volume":"9","author":"Chimerel","year":"2014","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0325","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2362.2010.02441.x","article-title":"Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy","volume":"41","author":"Alexander","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0330","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1253\/circj.CJ-15-0749","article-title":"Role of gut-derived protein-bound uremic toxins in Cardiorenal syndrome and potential treatment modalities","volume":"79","author":"Lekawanvijit","year":"2015","journal-title":"Circ. J."},{"issue":"14","key":"10.1016\/j.yjmcc.2020.12.001_bb0335","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-Dialysable uremic toxin","volume":"7","author":"Lekawanvijit","year":"2012","journal-title":"PLOS ONE."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0345","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0350","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1253\/circj.CJ-12-0715","article-title":"Association between Indoxyl sulfate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy","volume":"77","author":"Shimazu","year":"2013","journal-title":"Circ. J."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109268","article-title":"Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells","volume":"9","author":"Yisireyili","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0360","first-page":"C685","article-title":"CREB, NF-\u03baB, and NADPH oxidase coordinately upregulate indoxyl sulfate-induced angiotensinogen expression in proximal tubular cells","volume":"304","author":"Shimizu","year":"2013","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0365","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0370","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/0886022X.2018.1561376","article-title":"Review of the efficacy of AST-120 (KREMEZIN\u00ae) on renal function in chronic kidney disease patients","volume":"41","author":"Asai","year":"2019","journal-title":"Ren. Fail."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0385","first-page":"535","article-title":"Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD","volume":"23","author":"Shibahara","year":"2010","journal-title":"Journal of Nephrology."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.1978.tb00645.x","article-title":"An in vivo investigation of the negative chronotropic effect of Cholic acid in the rat","volume":"5","author":"Joubert","year":"1978","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.12.001_bb0395","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0006-2952(00)00259-8","article-title":"The effects of bile acids on \u03b2-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes","volume":"59","author":"Gazawi","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0400","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0405","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0410","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.78.072407.103733","article-title":"Sphingosine 1-phosphate receptor signaling","volume":"78","author":"Rosen","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0415","first-page":"215","article-title":"Deoxycholic acid conjugates are muscarinic cholinergic receptor antagonists","volume":"65","author":"Raufman","year":"2002","journal-title":"PHA."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0420","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF00177718","article-title":"Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes","volume":"335","author":"Binah","year":"1987","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0425","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0703554","article-title":"On the in vitro vasoactivity of bile acids","volume":"131","author":"Ljubuncic","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0430","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","article-title":"Increased secondary\/primary bile acid ratio in chronic heart failure","volume":"23","author":"Mayerhofer","year":"2017","journal-title":"J. Card. Fail."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2011.10.880","article-title":"Ursodeoxycholic acid in patients with chronic heart failure: A double-blind, randomized, placebo-controlled, crossover trial","volume":"59","author":"von Haehling","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6467","key":"10.1016\/j.yjmcc.2020.12.001_bb0440","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.aav3487","article-title":"Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy","volume":"366","author":"Gil-Cruz","year":"2019","journal-title":"Science."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fphar.2019.00107","article-title":"Glabridin prevents doxorubicin-induced cardiotoxicity through gut microbiota modulation and colonic macrophage polarization in mice","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0450","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ejhf.1439","article-title":"The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity","volume":"21","author":"Russo","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0455","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2014.11.003","article-title":"Histone deacetylases as therapeutic targets \u2014 from cancer to cardiac disease","volume":"147","author":"Abend","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0460","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCRESAHA.115.307604","article-title":"Chemical endoplasmic reticulum chaperone alleviates doxorubicin-induced cardiac dysfunction","volume":"118","author":"Ying","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000324","article-title":"Prevalence and prognostic impact of kidney disease on heart failure patients","volume":"3","author":"L\u00f6fman","year":"2016","journal-title":"Open Heart."},{"issue":"19","key":"10.1016\/j.yjmcc.2020.12.001_bb0470","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0480","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","article-title":"Targeted inhibition of gut microbial trimethylamine N-oxide production reduces renal Tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease","volume":"40","author":"Gupta","year":"2020","journal-title":"ATVB."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0485","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0490","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0495","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1067\/mhj.2001.116957","article-title":"Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up","volume":"142","author":"\u00c4rnl\u00f6v","year":"2001","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0500","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2004.03.037","article-title":"Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link","volume":"44","author":"Witteles","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.12.001_bb0505","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0510","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2008.08.081","article-title":"Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure","volume":"53","author":"ALZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, et al.","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0515","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0520","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0002-9149(99)00097-1","article-title":"Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and\/or aortic valve disease","volume":"83","author":"Paolisso","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2007.10.021","article-title":"Insulin-resistant cardiomyopathy: clinical evidence, mechanisms, and treatment options","volume":"51","author":"Witteles","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0530","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00129784-200404050-00001","article-title":"Impaired glucose metabolism in patients with heart failure","volume":"4","author":"Tenenbaum","year":"2004","journal-title":"Am J Cordiovosc Drugs."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.amjhyper.2004.11.038","article-title":"The Association of Heart Failure with Insulin Resistance and the development of type 2 diabetes","volume":"18","author":"Kostis","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0540","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1053\/j.gastro.2016.12.048","article-title":"Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction","volume":"152","author":"Bouter","year":"2017","journal-title":"Gastroenterology."},{"issue":"7452","key":"10.1016\/j.yjmcc.2020.12.001_bb0545","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0550","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.yjmcc.2020.12.001_bb0555","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","article-title":"Metabolic dysfunction in heart failure: diagnostic, prognostic, and pathophysiologic insights from Metabolomic profiling","volume":"13","author":"Hunter","year":"2016","journal-title":"Curr Heart Fail Rep."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0565","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0570","doi-asserted-by":"crossref","first-page":"E463","DOI":"10.1210\/jc.2014-2357","article-title":"Metabolomic profile associated with insulin resistance and conversion to diabetes in the insulin resistance atherosclerosis study","volume":"100","author":"Palmer","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7612","key":"10.1016\/j.yjmcc.2020.12.001_bb0575","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0580","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0585","first-page":"11(489)","article-title":"The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans","volume":"24","author":"Tirosh","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0590","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","article-title":"Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet","volume":"118","author":"Gao","year":"2014","journal-title":"J. Biosci. Bioeng."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0595","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3945\/ajcn.117.157107","article-title":"Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes","volume":"106","author":"Shan","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.12.001_bb0600","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0605","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.12.001_bb0610","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling \u2014 mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"17","key":"10.1016\/j.yjmcc.2020.12.001_bb0615","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0620","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fcimb.2019.00305","article-title":"Targeting the gut microbiota to treat Cachexia","volume":"9","author":"Genton","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.12.001_bb0625","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ejhf.1304","article-title":"Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"20","author":"Emami","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0630","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tem.2016.03.002","article-title":"Cytokine signaling in skeletal muscle wasting","volume":"27","author":"Zhou","year":"2016","journal-title":"Trends in Endocrinology & Metabolism."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0635","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/gut.48.4.503","article-title":"Modulation of colonic barrier function by the composition of the commensal flora in the rat","volume":"48","author":"Garcia-Lafuente","year":"2001","journal-title":"Gut."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.12.001_bb0640","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu10080988","article-title":"The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation","volume":"10","author":"Hiippala","year":"2018","journal-title":"Nutrients."},{"issue":"7762","key":"10.1016\/j.yjmcc.2020.12.001_bb0645","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature."},{"issue":"7698","key":"10.1016\/j.yjmcc.2020.12.001_bb0650","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature."},{"issue":"4594","key":"10.1016\/j.yjmcc.2020.12.001_bb0655","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.6836275","article-title":"Digoxin-inactivating bacteria: identification in human gut flora","volume":"220","author":"Saha","year":"1983","journal-title":"Science."},{"issue":"6143","key":"10.1016\/j.yjmcc.2020.12.001_bb0660","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1235872","article-title":"Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta","volume":"341","author":"Haiser","year":"2013","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0665","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HJH.0000000000000773","article-title":"Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction","volume":"34","author":"Yoo","year":"2016","journal-title":"J. Hypertens."},{"issue":"25","key":"10.1016\/j.yjmcc.2020.12.001_bb0670","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0675","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2015.08.039","article-title":"A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study","volume":"243","author":"Tektonidis","year":"2015","journal-title":"Atherosclerosis."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0680","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/nu10010058","article-title":"Mediterranean Diet and Other Dietary Patterns in Primary Prevention of Heart Failure and Changes in Cardiac Function Markers: A Systematic Review","volume":"10","author":"Sanches Machado d\u2019Almeida","year":"2018","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0685","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0690","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.12.001_bb0695","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.jacc.2019.01.067","article-title":"Dietary patterns and incident heart failure in U.S. adults without known coronary disease","volume":"73","author":"Lara","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0700","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amepre.2018.11.022","article-title":"Dietary approaches to stop hypertension diet concordance and incident heart failure: the multi-ethnic study of atherosclerosis","volume":"56","author":"Campos","year":"2019","journal-title":"Am. J. Prev. Med."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0705","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinternmed.2009.56","article-title":"Consistency with the DASH diet and incidence of heart failure","volume":"169","author":"Levitan","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.12.001_bb0710","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000495","article-title":"Ahmed Ali, Manson JoAnn E., et al. Mediterranean and DASH diet scores and mortality in women with heart failure","volume":"6","author":"Levitan","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.12.001_bb0715","first-page":"52","article-title":"Adherence to Mediterranean diet and all-cause mortality after an episode of acute heart failure: results of the MEDIT-AHF study","volume":"6","author":"Mir\u00f3","year":"2018","journal-title":"JACC: Heart Failure."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0720","doi-asserted-by":"crossref","first-page":"110584","DOI":"10.1016\/j.nut.2019.110584","article-title":"Mediterranean diet adherence and congestive heart failure: relationship with clinical severity and ischemic pathogenesis","volume":"70","author":"Tuttolomondo","year":"2020","journal-title":"Nutrition."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.12.001_bb0730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcmgh.2017.04.001","article-title":"Colonic microbiota encroachment correlates with Dysglycemia in humans","volume":"4","author":"Chassaing","year":"2017","journal-title":"Cellular and Molecular Gastroenterology and Hepatology."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0735","doi-asserted-by":"crossref","first-page":"699","DOI":"10.12688\/f1000research.18992.1","article-title":"Gut microbiome-Mediterranean diet interactions in improving host health","volume":"8","author":"Nagpal","year":"2019","journal-title":"F1000Res."},{"issue":"7682","key":"10.1016\/j.yjmcc.2020.12.001_bb0740","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates T H 17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0745","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/nu10091154","article-title":"A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model","volume":"10","author":"Bier","year":"2018","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.12.001_bb0750","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","article-title":"Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat","volume":"7","author":"Gan","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0755","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1096\/fj.11-197921","article-title":"Intestinal microbiota determine severity of myocardial infarction in rats","volume":"26","author":"Lam","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0760","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijcard.2014.11.034","article-title":"Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial","volume":"179","author":"Costanza","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.12.001_bb0765","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ehf2.12332","article-title":"Design of the GutHeart\u2014targeting gut microbiota to treat heart failure\u2014trial: a phase II, randomized clinical trial","volume":"5","author":"Mayerhofer","year":"2018","journal-title":"ESC Heart Failure."},{"key":"10.1016\/j.yjmcc.2020.12.001_bb0770","author":"Gullestad"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0775","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.12.001_bb0780","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.12.001_bb0785","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016223","article-title":"Nonlethal inhibition of gut microbial trimethylamine N-oxide production improves cardiac function and remodeling in a murine model of heart failure","volume":"9","author":"Organ","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.12.001_bb0790","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.12.001_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metabolism"},{"issue":"21","key":"10.1016\/j.yjmcc.2020.12.001_bb0800","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820303400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820303400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:33:13Z","timestamp":1758313993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820303400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":160,"alternative-id":["S0022282820303400"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.12.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}